Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy

International Urogynecology Journal

Volumn 19, Issue 11, 2008, Pages 1545-1550

  FitzGerald, M P ^a   Lemack, G ^b   Wheeler, T ^c   Litman, H J ^d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

Antimuscarinic therapy; Behavioral therapy; Lower urinary tract; Nocturia; Urge incontinence

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; TOLTERODINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; NOCTURIA; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS INCONTINENCE; SYMPTOM; TREATMENT DURATION; URGE INCONTINENCE; URINE INCONTINENCE;

EID: 53249100395     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-008-0687-7     Document Type: Article

References (16)

1. van Kerrerebroeck PAP, Chaikin D et al (2002) The standardisation of terminology in nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179-183
2. Asplund R, Aberg HE (2000) Nocturia and health in women aged 40-64 years. Maturitas 35:143-148
3. FitzGerald MP, Litman HJ, Link CL, McKinlay JB, for the BACH Survey Investigators (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: Results from the Boston Area Community Health (BACH) survey. J Urol 177:1385-1389
4. Coyne KS, Zhou Z, Battacharyya SK, Thompson CL, Dhawan R, Versi E (2003) The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 92:948
5. Asplund R, Aberg H (1992) Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 10:98-104
6. van Balen RSE, Polder JJ et al (2001) Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthopsedics and Relat Res 390:232-243
7. Asplund R (2006) Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr 43:319-326
8. Asplund R (2007) Pharmacotherapy for nocturia in the elderly patient. Drugs Aging 24:325-343
9. Johnson TM, Burgio KL, Reden DT, Wright KC, Goode PS (2005) Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 53:846-850
10. The Urinary Incontinence Treatment Network (2007) Design of the behavior enhances drug reduction of incontinence (BE-DRI) study. Contemporary Clinical Trials 28:48-58
11. Burgio KL, Kraus SR, Menefee S, Borello-France D, Corton M, Johnson HW, Mallett V, Norton P, FitzGerald MP, Dandreo KJ, Richter HE, Rozanski T, Albo M, Zyczynski HM, Lemack GE, Chai TC, Khandwala S, Baker J, Brubaker L, Stoddard AM, Goode PS, Nielsen-Omeis B, Nager C, Kenton K, Tennstedt SL, Kusek JW, Chang TD, Nyberg LM, Steers W for the Urinary Incontinence Treatment Network. (2008) Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: A randomized trial. Ann Intern Med 149:161-169
12. Diokno AC, Brock BM, Brown MB, Herzog AR (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136:1022-1025
13. Lowenstein L, Brubaker L, Kenton K, Kramer H, Shott S, FitzGerald MP (2007) Prevalence and impact of nocturia in a urogynecologic population. Int Urogynecol J 18:1049-1052
14. Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z, 037 Study Group (2007) Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 178:548-551
15. Brubaker L, FitzGerald MP (2007) Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogyn J 18:737-741
16. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z, 037 Study Group (2006) Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 67:731-736